TREX1 and neoplasm: Later on, the same group has shown that repeated medium-high doses, below a threshold of 10-12 Gy, do not induce DNA exonuclease Trex1, and thus elevates interferon-β production in tumor cells, which promotes recruitment and activation of Batf3-dependent DCs (50).